https://fortune.com/well/2022/09/24/new-covid-omicron-variants-subvariants-evade-monoclonal-antibodies-bebtelovimab-recombinants-convergent-evolution-sars-immune-evasion/
0
0
9/24/22 at 9:00am
Organization
Fortune
Author
Erin Prater
One up and coming variant renders society’s last universal COVID antibody drug powerless, experts say. Another variant isn’t far behind it.
Create an account
or login to join the discussion